Why is JFL Life falling/rising?

As of 03-Nov, JFL Life Sciences Ltd is experiencing a decline in its stock price, currently at 13.25, which reflects a decrease of 0.55 or 3.99%. Today's performance indicates that the stock has underperformed its sector by 5.29%, with a delivery volume that has fallen significantly by 48.28% compared to the 5-day average. Over the past week, the stock has shown a modest gain of 1.15%, but it has struggled in the longer term, with a year-to-date return of -56.91% and a one-year return of -40.32%. Despite a healthy long-term growth rate in operating profit of 34.76% and a return on capital employed (ROCE) of 14.4, the stock's recent performance has been hampered by flat results in June and a significant drop in net sales.
In the broader market context, JFL Life's short-term performance contrasts with the Sensex, which has seen a decline of 0.78% over the same week. While the stock has shown some resilience in the past month with a return of 3.92%, it has consistently underperformed against the BSE500 over the last three years, one year, and three months. This underperformance, combined with the recent drop in investor participation and liquidity concerns, suggests a challenging environment for the stock, leading to its current downward trajectory.